Skip to content
AwardedPRTGoodsFramework agreement€1,311,532

2025/1303 - TRASTUZUMAB DERUXTECANO [100 MG PÓ CONC SOL INJ FRS]

Published
Published 7 July 2026

Overview

Unidade Local de Saúde Santa Maria procured Trastuzumab Deruxtecano [100 mg powder concentrate for solution for injection in vials], a pharmaceutical product for oncology treatment. The contract was awarded to DAIICHI SANKYO PORTUGAL, LDA on 28 April 2026 for €1,311,531.60.

Key details

Country
PRT
Status
Awarded
Category
Goods
Estimated value
€1,311,532
Procedure
Selective
Contract type
Framework agreement
Published
7 July 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€1,311,532
Award date
28 April 2026
Contract period
— → 24 December 2026
Winner
  • DAIICHI SANKYO PORTUGAL , LDA

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    7 July 2026

Contracting authority

  • Unidade Local de Saúde Santa Maria, E.P.E.

    Procuring entity

    Lisboa, PRT

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: 2025/1303 - TRASTUZUMAB DERUXTECANO [100 MG PÓ CONC SOL INJ FRS] — won by DAIICHI SANKYO PORTUGAL , LDA — Skim